Intuitive Surgical

Company Overview

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.

Industry

Health Care Equipment

Financial Summary

Revenue (TTM)

$6.22B

Net Income (TTM)

$1.32B

Total Assets

$15.44B

Total Debt

-

Total Equity

$13.31B

Market Cap

-

Valuation Metrics

P/E Ratio

-

P/B Ratio

-

Profit Margin

21.25%

ROE

9.94%

ROA

8.56%

Dividend Yield

-

More Health Care Stocks